Authors: Hodgetts, SI Grounds, MD

Citation: Si. Hodgetts et Md. Grounds, Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, butnot in the absence of C5, IMM CELL B, 79(3), 2001, pp. 231-239

Authors: Smythe, GM Hodgetts, SI Grounds, MD

Citation: Gm. Smythe et al., Immunobiology and the future of myoblast transfer therapy, MOL THER, 1(4), 2000, pp. 304-313

Authors: Hodgetts, SI Beilharz, MW Scalzo, AA Grounds, MD

Citation: Si. Hodgetts et al., Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4(+) and CD8(+) cells or NK1.1(+) cells, CELL TRANSP, 9(4), 2000, pp. 489-502

Authors: Urosevic, N Silvia, OJ Sangster, MY Mansfield, JP Hodgetts, SI Shellam, GR

Citation: N. Urosevic et al., Development and characterization of new flavivirus-resistant mouse strainsbearing Flv(r)-like and Flv(mr) alleles from wild or wild-derived mice, J GEN VIROL, 80, 1999, pp. 897-906